BMS-779788

1 1

Selleck Chemicals

E8136

€0,00 EUR
€0,00 EUR
Sold out
Shipping calculated at checkout.
Size
View full details

BMS-779788 is an agonist of LXR used in studies of Metabolic Signaling. It is especially relevant in endocrinology, immunology, and inflammation models, where defined compound exposure can be linked to metabolic regulation, energy sensing, and enzyme-linked homeostasis.

By activating LXR, BMS-779788 can be used to examine metabolic regulation, energy sensing, and enzyme-linked homeostasis. The nuclear receptor annotation adds relevance to reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping in the same experimental setting. In endocrinology, immunology, and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving LXR
  • Pathway perturbation studies connected to Metabolic Signaling
  • Agonist-response and downstream signaling studies
  • Reporter-gene, receptor-binding, and transcriptional assays

Overall, BMS-779788 is appropriate when a defined chemical perturbant is needed to connect LXR with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in endocrinology, immunology, and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
LXR
Target Class:
Nuclear Receptor
Pathways:
Metabolic Signaling
Research Area:
Endocrinology • Immunology • Inflammation • Metabolism
CAS No.:
918348-67-1
Molecular Weight:
509.06
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.